52
23
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73146 | FGFR3-IN-5 | ||
FGFR3-IN-5 是一种有效的选择性 FGFR3抑制剂,对 FGFR3、FGFR2 和 FGFR1的 IC50值分别为 3、44、和 289 nM。FGFR3-IN-5 可用于癌症的研究。 | |||
T64107 |
FGFR3-IN-1
|
||
FGFR3-IN-1 (compound 1) 是一种成纤维细胞生长因子受体 (FGFR) 抑制剂,可抑制FGFR1 (IC50: 40 nM),FGFR2 (IC50: 5.1 nM) 和 FGFR3 (IC50: 12 nM)。FGFR3-IN-1 能够用于研究膀胱癌。 | |||
T82405 |
FGFR3-IN-6
|
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FGFR3-IN-6为FGFR3选择性抑制剂,具有低于350 nM 的IC50,适用于癌症研究领域。 | |||
T64215 | FGFR3-IN-2 | ||
FGFR3-IN-2 (compound 18b) 是一种有效的、选择性的 FGFR3 抑制剂,能够抑制 FGFR3 (IC50: 4.1 nM) 和 VEGFR2 (IC50: 570 nM)。FGFR3-IN-2 能够用于研究膀胱癌。 | |||
T73145 |
FGFR3-IN-4
|
||
FGFR3-IN-4 是一种选择性的 FGFR3抑制剂,IC50值小于 50 nM。FGFR3-IN-4 对 FGFR3的选择性至少比FGFR1高 10 倍。 | |||
T82404 | FGFR3-IN-7 | FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FGFR3-IN-7为高选择性FGFR3抑制剂,显示出小于350 nM 的IC50效价,主要用于癌症相关研究。 | |||
T8492 |
BO-264
|
Apoptosis; FGFR | Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors |
BO-264 是一种有口服活性的转化酸性卷曲螺旋 3 抑制剂,可特异性阻断 FGFR3-TACC3融合蛋白的功能。它诱导纺锤体检查点依赖的有丝分裂阻滞,DNA 损伤和细胞凋亡,具有广谱抗肿瘤活性。 | |||
T6479 |
Dovitinib lactate hydrate
Dovitinib (TKI258) Lactate,多韦替尼,Dovitinib Lactate,TKI258 |
VEGFR; FGFR; FLT; PDGFR; c-Kit | Angiogenesis; Tyrosine Kinase/Adaptors |
Dovitinib lactate hydrate (TKI258) 是一种多靶点的酪氨酸激酶抑制剂,抑制 FLT3,c-Kit,FGFR1/3,VEGFR1/2/3和 PDGFRα/β的 IC50值分别为 1,2,8/9,10/13/8,27/210 nM。 | |||
T16364 |
Infigratinib phosphate
NVP-BGJ398 phosphate,BGJ-398 phosphate |
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Infigratinib phosphate (BGJ-398 phosphate) 是 FGFR 抑制剂,对 FGFR1,FGFR2 和 FGFR3 的 IC50 分别为0.9,1.4 和 1 nM,比对 FGFR4 和 VEGFR2 的抑制性高40倍,对 Abl,Fyn,Kit,Lck 和 Lyn 几乎无活性。 | |||
TQ0228 |
Derazantinib
ARQ-087 |
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Derazantinib (ARQ-087) 是一种有效的,ATP 竞争型的,具有口服活性的酪氨酸激酶抑制剂,能够抑制软骨细胞FGFR1 (IC50:4.5 nM)、FGFR2 (IC50:1.8 nM)、FGFR3 (IC50:4.35nM)。 | |||
T7104 |
Dovitinib lactate
CHIR-258 lactate,多韦替尼乳酸盐,TKI-258 lactate |
VEGFR; FGFR; FLT; PDGFR; c-Kit | Angiogenesis; Tyrosine Kinase/Adaptors |
Dovitinib lactate (TKI-258 lactate) 是一种多靶点的酪氨酸激酶抑制剂,抑制FLT3,c-Kit,FGFR1/3,VEGFR1/2/3和PDGFRα/β的IC50值分别为 1,2,8/9,10/13/8,27/210 nM。 | |||
T12401 |
Pemigatinib
INCB054828 |
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Pemigatinib (INCB054828) 是一种口服具有活力的,选择性的 FGFR 抑制剂,能够作用于 FGFR1 (IC50:0.4 nM),FGFR2 (IC50:0.5 nM),FGFR3 (IC50:1.2 nM),FGFR4 (IC50:30 nM),有用于胆管癌的潜力。 | |||
T6024 |
Zoligratinib
FF284,CH5183284,Debio 1347 |
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Zoligratinib (CH5183284) 是一种口服具有活力的,选择性的FGFR 抑制剂,能够抑制FGFR1 (IC50:9.3 nM),FGFR2 (IC50:7.6 nM),FGFR3 (IC50:22 nM),FGFR4 (IC50:290 nM)。 | |||
T61304 |
FGFR2-IN-1
|
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FGFR2-IN-1是一种 FGFR 抑制剂,对 FGFR1、FGFR2和FGFR3具有抑制作用, IC50 分别为460、140和2200 nM。FGFR2-IN-1 可用于研究与 FGFR2 相关的癌症。 | |||
T2361 |
LY2874455
LY 2874455,LY-2874455 |
VEGFR; FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
LY2874455 是pan-FGFR 抑制剂,能够抑制FGFR1 (IC50:2.8 nM),FGFR2 (IC50:2.6 nM),FGFR3 (IC50:6.4 nM),FGFR4 (IC50:6 nM)。 | |||
T3466 |
FIIN-3
|
EGFR; FGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
FIIN-3 是FGFR 的不可逆抑制剂,对FGFR1、FGFR2、FGFR3和FGFR4的IC50值分别为13.1、21、31.4和35.3 nM。 | |||
T76877 |
Vofatamab
RG-7444,B-701,MFGR-1877S |
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Vofatamab (B-701) 是一种全人源靶向 FGFR3 的单克隆抗体。Vofatamab 具有潜在的抗癌抗肿瘤活性,常与其他化合物联用来治疗癌症。 | |||
T6028 |
PF 477736
PF 00477736,PF-477736,PF-736,PF-00477736,PF477736 |
c-Fms; VEGFR; FGFR; FLT; c-RET; Chk; CDK; Src; Aurora Kinase | Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors |
PF 477736 (PF-736,PF-00477736) 是一种特异性、有效且具有 ATP 竞争性的 Chk1 抑制剂,Ki 值为0.49 nM。它也是Chk2抑制剂,Ki 值为 47 nM。它还抑制VEGFR2、Fms、Yes、Aurora-A、FGFR3、Flt3和Ret。 | |||
T1777 |
Nintedanib
BIBF 1120,Intedanib,尼达尼布 |
VEGFR; FGFR; FLT; PDGFR; Src | Angiogenesis; Tyrosine Kinase/Adaptors |
Nintedanib (Intedanib) 是一种三重血管激酶抑制剂,抑制 VEGFR1、VEGFR2、VEGFR3 (IC50=34/13/13 nM),FGFR1、FGFR2、FGFR3 (IC50=69/37/108 nM),PDGFRα、PDGFRβ (IC50=59/65 nM)。Nintedanib 具有抗肿瘤活性,通过抑制血管生成来抑制肿瘤生长。 | |||
T1948 |
AZD4547
|
VEGFR; FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
AZD4547 是FGFR 家族抑制剂,能够作用于FGFR1 (IC50:0.2 nM),FGFR2 (IC50:2.5 nM),FGFR3 (IC50:1.8 nM) 和FGFR4 (IC50:165 nM)。 | |||
T6435 |
CCT129202
2-[4-[6-氯-2-(4-二甲基氨基苯基)-3H-咪唑并[4,5-B]吡啶-7-基]哌嗪-1-基]-N-(噻唑-2-基)乙酰胺 |
Aurora Kinase | Cell Cycle/Checkpoint; Chromatin/Epigenetic |
CCT129202 是一种 ATP 竞争性泛极光激酶抑制剂,作用于 Aurora A、Aurora B 和 Aurora C,IC50 分别为 0.042 μM、0.198 μM 和 0.227 μM。 | |||
T6836 |
FIIN-2
|
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FIIN2 是一种 FGFR 的不可逆抑制剂,能够抑制 FGFR1 (IC50:3.1 nM),FGFR2 (IC50:4.3 nM),FGFR3 (IC50:27 nM) 和 FGFR4 (IC50:45 nM)。 | |||
T1975 |
Infigratinib
BGJ-398,NVP-BGJ398 |
Apoptosis; FGFR | Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors |
Infigratinib (NVP-BGJ398) 是一种 FGFR 家族抑制剂,抑制 FGFR1,FGFR2,FGFR3和 FGFR4的 IC50分别为 0.9 nM,1.4 nM,1 nM,60 nM。 | |||
T5122 |
Alofanib
RPT835 |
Apoptosis; FGFR | Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors |
Alofanib (RPT835) 是一种高效和选择性的成纤维细胞生长因子受体2的变构抑制剂,具有抗癌和抗血管生成活性。 | |||
TQ0015 |
PRN1371
|
c-Fms; FGFR; CSF-1R | Angiogenesis; Tyrosine Kinase/Adaptors |
PRN1371 是一种高效的、选择性的FGFR1-4和CSF1R 抑制剂,对FGFR1,FGFR2,FGFR3,FGFR4 和 CSF1R 的IC50值分别为 0.6,1.3,4.1,19.3 和 8.1 nM。 | |||
T5001 |
Nintedanib esylate
Intedanib,乙磺酸尼达尼布,BIBF 1120 (esylate),尼达尼布乙磺酸盐,Nintedanib Ethanesulfonate Salt,BIBF 1120 |
VEGFR; FGFR; PDGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Nintedanib esylate (BIBF 1120 esylate) 是一种有效的三重血管激酶抑制剂,能够抑制 VEGFR1 (IC50:34 nM)、VEGFR2 (IC50:13 nM)、VEGFR3 (IC50:13 nM),FGFR1 (IC50:69 nM)、FGFR2 (IC50:37 nM)、FGFR3 (IC50:108 nM),PDGFRα (IC50:59 nM)、PDGFRβ (IC50:65 nM)。 | |||
T2609 |
Masitinib
AB1010,马赛替尼 |
Apoptosis; FAK; c-Fms; FGFR; Bcr-Abl; PDGFR; Src; c-Kit; Hck | Angiogenesis; Apoptosis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Masitinib (AB1010) 是生物口服可利用的选择性 c-Kit 抑制剂 (对于人重组c-Kit,IC50=200 nM),它还抑制PDGFRα/β(IC50s=540/800 nM),Lyn(对 LynB 的IC50=510 nM),Lck,较小程度上抑制FGFR3和FAK。它有抗增殖,促凋亡活性,且毒性低。 | |||
T37426 |
FIIN-1
FGFR irreversible inhibitor-1 |
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FIIN-1 (FGFR irreversible inhibitor-1) 是一种不可逆具有选择性的 FGFR 抑制剂,对 FGFR1、FGFR2、FGFR3、FGFR4、 Flt1、Flt14 的 Kd 分别为 2.8、6.9、5.4、120 ,32和120 nM。FIIN-1 对FGFR1、FGFR2、FGFR3和FGFR4 具有抑制作用, IC50 分别是 9.2,6.2,11.9 和 189 nM。 | |||
T2347 |
BLU9931
|
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
BLU9931 是高度选择性的,不可逆的成纤维细胞生长因子受体 4 抑制剂,其 IC50=3 nM,Kd=6 nM,具有抗肿瘤作用。 | |||
T64125 | FGFR-IN-8 | ||
FGFR-IN-8 一种高效的、口服具有活力的 FGFR 抑制剂,可抑制野生型和突变型 FGFR。 FGFR-IN-8 能够作用于 FGFR1 (IC50<0.5 nM)、V564F-FGFR2 (IC5016: 189.1 nM)、N549H-FGFR2 (IC50<0.5 nM)、V555M-FGFR3 (IC50: 22.6 nM)、FGFR3 (IC50<0.5 nM) 和 FGFR 4 (IC50: 7.30 nM)。FGFR-IN-8 能够诱导癌细胞凋亡(apoptosis),表现出抗癌效果。 | |||
T74462 | SNIPER(TACC3)-11 | ||
SNIPER(TACC3)-11是一种针对FGFR3-TACC3的有效抑制剂,能够降低FGFR3-TACC3蛋白水平,并抑制FGFR3-TACC3阳性癌细胞增殖。 | |||
T5473 |
ASP5878
ASP-5878 |
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
ASP5878 是一种 FGFR 1 (IC50:0.47 nM)、FGFR 2 (IC50:0.6 nM)、FGFR 3 (IC50:0.74 nM)、和 FGFR 4 (IC50:3.5 nM)的抑制剂,具有口服活性,具有潜在的抗肿瘤作用。 | |||
T76367 |
VSPPLTLGQLLS
|
||
VSPPLTLGQLLS为一种针对FGFR3的小肽抑制剂,属于肽P3类,具有抑制FGFR3磷酸化的能力。该化合物能阻断9-cisRA诱导的气管淋巴管生成,并抑制淋巴内皮细胞(LEC)的增殖、迁移和小管形成。 | |||
T77145 | Recifercept | ||
Recifercept (TA-46) 是一种溶解性重组FGFR3分子,能够作为诱饵/配体陷阱,降低与突变FGFR3受体结合的成纤维细胞生长因子数量,用于研究软骨发育不全。 | |||
T72749 |
E7090 succinate
|
||
E7090 succinate 是具有口服活性的、选择性的、有效的 FGFR1/2/3抑制剂,其对 FGFR1/2/3/4 的 IC50值分别为 0.71 nM、0.50 nM、1.2 nM 和120 nM。 | |||
T76368 |
VSPPLTLGQLLS TFA
|
||
VSPPLTLGQLLS TFA为FGFR3小肽抑制剂,属于肽P3类,可阻断FGFR3磷酸化。该化合物能够抑制9-cisRA诱导的气管淋巴管生成,同时抑止淋巴内皮细胞(LEC)的增殖、迁移及小管形成。 | |||
T10997 |
Derazantinib Racemate
ARQ-087 Racemate |
Others | Others |
Derazantinib Racemate (ARQ-087 Racemate) 是 Derazantinib 的外消旋体。Derazantinib 是一种有效的,ATP 竞争型的,具有口服活性的酪氨酸激酶抑制剂,能够抑制软骨细胞 FGFR1 (IC50:4.5 nM)、FGFR2 (IC50:1.8 nM)、FGFR3 (IC50:4.5nM)。 | |||
T76277 |
Vosoritide
|
||
Vosoritide (BMN 111) 为改良重组CNP (C型钠尿肽) 类似物,作用于NPR-B (B型钠尿肽受体),能有效降低FGFR3 (成纤维细胞生长因子受体 3) 活性,主要应用于软骨症和侏儒症研究领域。 | |||
T3726 |
Erdafitinib
厄达替尼,JNJ-42756493 |
Apoptosis; FGFR | Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors |
Erdafitinib (JNJ-42756493) 是一种喹喔啉衍生物,是一种具有口服活性的FGFR 家族抑制剂,抑制FGFR1/2/3/4活性的IC50分别为1.2、 2.5、3.0和5.7 nM。 | |||
T62652 |
CPL304110
|
||
CPL304110 是一种口服具有活力的、选择性的、有效的成纤维细胞生长因子受体 FGFR (1-3) 的抑制剂,能够作用于 FGFR1 (IC50: 0.75 nM)、 FGFR2 (IC50: 0.5 nM)、FGFR3 (IC50: 3.05 nM) 。 | |||
T62682 |
FGFR4-IN-10
|
||
FGFR4-IN-10 (compound 5a) 是一种选择性的、有效的 FGFR4 抑制剂 (IC50: 70.7 nM)。FGFR4-IN-10 不能抑制其他 FGFR 家族成员 (即 FGFR1、FGFR2 和 FGFR3)。 | |||
T73316 | FGFR-IN-9 | ||
FGFR-IN-9 是一种有效的、可逆的、具有口服活性的FGFR 抑制剂,对FGFR4WT、FGFR3、FGFR4V550L、FGFR2 和FGFR1的IC50分别为 17.1、29.6、30.7、46.7 和 64.3 nM。 | |||
T39001 |
FGFR-IN-1
|
||
FGFR-IN-1 is a highly effective inhibitor targeting the Fibroblast Growth Factor Receptor (FGFR) group, comprising FGFR1, FGFR2, and FGFR3, with an impressive inhibitory concentration (IC 50) of less than 100 nM (US20130338134A1, example 219). | |||
T62653 |
FGFR-IN-2
|
||
FGFR-IN-2 (compound 1) 是一种有效的 FGFR 抑制剂,能够作用于 FGFR1 (IC50: 7.3 nM)、FGFR2 (IC50: 4.3 nM)、FGFR3 (IC50: 7.6 nM) 和 FGFR4 (IC50: 11 nM)。FGFR-IN-2 具有潜力进行癌症研究。 | |||
T70276 |
Roridin E
|
||
Roridin E inhibits the receptor tyrosine kinases FGFR3, IGF-1R, PDGFRβ, and TrkB (IC50s = 0.4, 0.4, 1.4, and 1 μM, respectively) and induces cytotoxicity in multiple breast cancer cell lines (IC50s = 0.02-0.05 nM). It also inhibits proliferation in a panel of additional cancer cell lines (IC50s = <0.01 μM). | |||
T79257 | FGFR-IN-11 | FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FGFR-IN-11(compound I-5)是一款具备口服活性的共价pan-FGFR抑制剂,对FGFR1至FGFR4的IC50值分别为9.9 nM、3.1 nM、16 nM和1.8 nM。该化合物能够在纳摩尔水平有效抑制多种肿瘤细胞的增殖,并在荷瘤小鼠模型中显著地抑制肿瘤生长。 | |||
T73179 |
HDAC-IN-50
|
||
HDAC-IN-50是一种口服活性的有效FGFR和HDAC双重抑制剂,其IC50值针对FGFR1、FGFR2、FGFR3、FGFR4、HDAC1、HDAC2、HDAC6、HDAC8分别为0.18、1.2、0.46、1.4、1.3、1.6、2.6、13 nM。该化合物能诱导(Apoptosis)及使细胞周期在G0/G1期停滞,降低pFGFR1、pERK、pSTAT3的表达,展现出抗肿瘤活性。 | |||
T3274 |
S49076
|
FGFR; c-Met/HGFR; TAM Receptor | Angiogenesis; Tyrosine Kinase/Adaptors |
S49076 是一种新型 MET、AXL/MER 和 FGFR1/2/3 高效抑制剂,IC50<20 nM。 | |||
T7611 |
ODM-203
|
VEGFR; FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
ODM-203 是 FGFR 和 VEGFR 家族的抑制剂,具有显著的抗肿瘤活性,能够诱导抗肿瘤免疫。 | |||
T1886 |
TAK-632
|
Raf; FGFR; PDGFR; Aurora Kinase | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; MAPK; Tyrosine Kinase/Adaptors |
TAK632 是一种有效的pan-RAF 抑制剂,对CRAF、BRAFV600E 和BRAFWT 的IC50分别为 1.4、2.4 和 8.3 nM。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00341 |
FGFR3 Protein, Human, Recombinant (alpha IIIb, His)
CEK2,HSFGFR3EX,fibroblast growth factor re... |
Human | HEK293 Cells |
FGFR3 Protein, Human, Recombinant (alpha IIIb, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 40 kDa and the accession number is P22607-2. | |||
TMPK-00387 |
FGFR3 beta (IIIc) Protein, Human, Recombinant (His & Avi), Biotinylated
HSFGFR3EX,FGF R3,EC 2.7.10,CD... |
Human | HEK293 Cells |
Four distinct genes encoding closely related FGF receptors, FGF R1-4, are known. All four genes for FGF Rs encode proteins with an N-terminal signal peptide, three immunoglobulin (Ig)-like domains, an acid‑box region containing a run of acidic residues between the IgI and IgII domains, a transmembrane domain and the split tyrosine-kinase domain.FGFR3 is tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell p... | |||
TMPK-00384 |
FGFR3 alpha (IIIc) Protein, Human, Recombinant (His & Avi)
CD333,EC 2.7.10,JTK4,FGFR |
Human | HEK293 Cells |
FGFR3 alpha (IIIc) Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 41.1 kDa and the accession number is P22607. | |||
TMPK-00391 |
FGFR3 beta (IIIb) Protein, Human, Recombinant (His & Avi), Biotinylated
HSFGFR3EX,FGFR3,FGF R |
Human | HEK293 Cells |
Four distinct genes encoding closely related FGF receptors, FGF R1-4, are known. All four genes for FGF Rs encode proteins with an N-terminal signal peptide, three immunoglobulin (Ig)-like domains, an acid‑box region containing a run of acidic residues between the IgI and IgII domains, a transmembrane domain and the split tyrosine-kinase domain.FGFR3 is tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell p... | |||
TMPY-04165 |
FGFR3 Protein, Human, Recombinant (His)
JTK4,CEK2,fibroblast growth factor receptor 3,HS |
Human | HEK293 Cells |
FGFR3 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 39.6 kDa and the accession number is P22607-1. | |||
TMPK-00686 |
FGFR3 alpha (IIIb) Protein, Mouse, Recombinant (His)
CEK,CD333,HSFGFR3 |
Mouse | HEK293 Cells |
FGFR3 alpha (IIIb) Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 37.09 kDa and the accession number is E9QNJ9. | |||
TMPK-00385 |
FGFR3 beta (IIIc) Protein, Human, Recombinant (His & Avi)
FGFR3,EC 2.7.10,FGFR3 β ... |
Human | HEK293 Cells |
FGFR3 beta (IIIc) Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 30.1 kDa and the accession number is P22607-1. | |||
TMPK-00389 |
FGFR3 beta (IIIb) Protein, Human, Recombinant (His & Avi)
FGFR3,FGFR3 β (IIIb),CD<... |
Human | HEK293 Cells |
FGFR3 beta (IIIb) Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 30.5 kDa and the accession number is P22607-2. | |||
TMPK-00386 |
FGFR3 alpha (IIIc) Protein, Human, Recombinant (His & Avi), Biotinylated
ACH,CD333,EC 2.7.10,FGFR... |
Human | HEK293 Cells |
FGFR3 alpha (IIIc) Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 41.1 kDa and the accession number is P22607. | |||
TMPK-00390 |
FGFR3 alpha (IIIb) Protein, Human, Recombinant (His & Avi), Biotinylated
FGFR3,JTK4,ACH,FGF R3,FGFR |
Human | HEK293 Cells |
FGFR3 alpha (IIIb) Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 41.4 kDa and the accession number is P22607-2. | |||
TMPK-00388 |
FGFR3 alpha (IIIb) Protein, Human, Recombinant (His & Avi)
HSFGFR3EX,FGF R3,ACH,CD3... |
Human | HEK293 Cells |
FGFR3 alpha (IIIb) Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 41.4 kDa and the accession number is P22607-2. | |||
TMPY-00389 |
FGFR3 Protein, Human, Recombinant (alpha IIIb, hFc)
ACH,HSFGFR3EX,fibroblast growth factor rec... |
Human | HEK293 Cells |
FGFR3 Protein, Human, Recombinant (alpha IIIb, hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 65.3 kDa and the accession number is P22607-2. | |||
TMPY-04200 |
FGFR3 Protein, Human, Recombinant (hFc)
CD333,HSFGFR3EX... |
Human | HEK293 Cells |
FGFR3 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 64.9 kDa and the accession number is P22607-1. | |||
TMPY-01208 |
FGFR3 Protein, Mouse, Recombinant (His)
fibroblast growth factor receptor 3,Mfr3,H... |
Mouse | HEK293 Cells |
FGFR3 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 37 kDa and the accession number is Q7TSI8. | |||
TMPY-00257 |
FGFR3 Protein, Cynomolgus, Rhesus, Recombinant (His)
fibroblast growth factor receptor 3 |
Cynomolgus,Rhesus | HEK293 Cells |
FGFR3 Protein, Cynomolgus, Rhesus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 39.5 kDa and the accession number is XP_005554344.1. | |||
TMPY-02853 |
FGFR3 Protein, Cynomolgus, Recombinant (hFc)
fibroblast growth factor receptor 3 |
Cynomolgus | HEK293 Cells |
FGFR3 Protein, Cynomolgus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 65.1 kDa and the accession number is F7FZR9. | |||
TMPY-00973 |
FGFR3 Protein, Mouse, Recombinant (His & hFc)
FR3,Fgfr-3,Flg-2,CD3... |
Mouse | HEK293 Cells |
FGFR3 Protein, Mouse, Recombinant (His & hFc) is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 66 kDa and the accession number is Q7TSI8. | |||
TMPY-03104 |
FGF-17 Protein, Human, Recombinant
fibroblast growth factor 17,HH20,FGF-13,FGF-17 |
Human | E. coli |
FGF-13, also known as FGF17, belongs to the fibroblast growth factor (FGF) family. Members of this family show broad mitogenic and cell survival activities, and play a role in a variety of biological processes including embryonic development cell growth, morphogenesis, tissue repair, tumor growth and invasion. FGF-13 is preferentially expressed in the embryonic brain. It interacts with FGFR3 and FGFR4. FGF-13 plays an important role in the regulation of embryonic development and as signaling mol... | |||
TMPY-02907 |
FGF-19 Protein, Human, Recombinant
fibroblast growth factor 19,FGF19 |
Human | E. coli |
FGF19, also known as FGF-19, is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. FGF19 interacts with FGFR1, FGFR2, FGFR3 and FGFR4. Affinity between fibroblast growth factors (FGFs) and their receptors is increased by KL, KLB and heparan sulfate glycosaminoglyca... | |||
TMPH-00369 |
FGF-2 Protein, Chicken, Recombinant (His & Myc)
|
Chicken | E. coli |
Acts as a ligand for FGFR1, FGFR2, FGFR3 and FGFR4. Also acts as an integrin ligand which is required for FGF2 signaling. Plays an important role in the regulation of cell survival, cell division, cell differentiation and cell migration. Functions as a potent mitogen in vitro. Can induce angiogenesis. FGF-2 Protein, Chicken, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 23.8 kDa and the accession number is P48800. | |||
TMPH-00368 |
FGF-2 Protein, Chicken, Recombinant (His)
|
Chicken | P. pastoris (Yeast) |
Acts as a ligand for FGFR1, FGFR2, FGFR3 and FGFR4. Also acts as an integrin ligand which is required for FGF2 signaling. Plays an important role in the regulation of cell survival, cell division, cell differentiation and cell migration. Functions as a potent mitogen in vitro. Can induce angiogenesis. FGF-2 Protein, Chicken, Recombinant (His) is expressed in yeast with N-6xHis tag. The predicted molecular weight is 18.3 kDa and the accession number is P48800. | |||
TMPH-03203 |
FGFb Protein, Rabbit, Recombinant (His & SUMO)
|
Rabbit | E. coli |
Acts as a ligand for FGFR1, FGFR2, FGFR3 and FGFR4. Also acts as an integrin ligand which is required for FGF2 signaling. Binds to integrin ITGAV:ITGB3. Plays an important role in the regulation of cell survival, cell division, cell differentiation and cell migration. Functions as a potent mitogen in vitro. Can induce angiogenesis. Mediates phosphorylation of ERK1/2 and thereby promotes retinal lens fiber differentiation. FGFb Protein, Rabbit, Recombinant (His & SUMO) is expressed in E. coli exp... | |||
TMPY-02240 |
STAT1 Protein, Human, Recombinant (His & GST)
IMD31A,IMD31B,IMD31C,STAT91,CANDF... |
Human | Baculovirus Insect Cells |
STAT1 is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor-associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. STAT1 can be activated by various ligands, including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. It is a signal transducer and transcription activator that mediates cellular responses to interferons (IFNs),... |